Uncommon EGFR mutations in a cohort of Chinese NSCLC patients and outcomes of first-line EGFR-TKIs and platinum-based chemotherapy

OBJECTIVE: Data on the clinical activity of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in patients with non-small-cell lung cancer (NSCLC) and uncommon EGFR mutations remain insufficient. This study aimed to investigate the effect of first-line EGFR-TKIs or platinum-ba...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Chin J Cancer Res
Main Authors: Shi, Jinpeng, Yang, Hui, Jiang, Tao, Li, Xuefei, Zhao, Chao, Zhang, Limin, Zhao, Sha, Liu, Xiaozhen, Jia, Yijun, Wang, Yan, Xi, Lei, Zhang, Shijia, Su, Chunxia, Ren, Shengxiang, Zhou, Caicun
Formato: Artigo
Idioma:Inglês
Publicado: AME Publishing Company 2017
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5775013/
https://ncbi.nlm.nih.gov/pubmed/29353977
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21147/j.issn.1000-9604.2017.06.09
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares